Celcuity (CELC) Enterprise Value (2016 - 2025)
Celcuity (CELC) reported Enterprise Value of -$717.3 million for Q4 2025, down 205.12% on a YoY basis from $682.4 million in Q4 2024, and down 57.65% quarter-over-quarter from -$455.0 million in Q3 2025.
Celcuity (CELC) Enterprise Value (2016 - 2025) Analysis & Trends
Celcuity has reported Enterprise Value for 10 years, with the latest figure at -$717.3 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 205.12% year-over-year to -$717.3 million; the trailing twelve-month figure through Dec 2025 stood at -$717.3 million (down 205.12% YoY), and the FY2025 full-year result was -$717.3 million, down 205.12% from the prior year.
- Enterprise Value for Q4 2025 stood at -$717.3 million, down from -$455.0 million in the prior quarter.
- The five-year high for Enterprise Value was -$32.3 million in Q2 2023, with the low at -$717.3 million in Q4 2025.
- Historically, Enterprise Value has averaged -$175.5 million across 5 years, with a median of -$151.2 million in 2023.
- Annual changes were most pronounced in 2023 — Enterprise Value soared 57.02% — and 2024, when it tumbled 777.44%.
- Celcuity's Enterprise Value stood at -$84.3 million in 2021, then sank by 99.97% to -$168.6 million in 2022, then declined by 7.12% to -$180.6 million in 2023, then sank by 30.18% to -$235.1 million in 2024, then plunged by 205.12% to -$717.3 million in 2025.
- The last three Enterprise Value figures came in at -$717.3 million (Q4 2025), -$455.0 million (Q3 2025), and -$168.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -584.73 Mn |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | -717.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -717.29 Mn |
| Sep 30, 2025 | -454.98 Mn |
| Jun 30, 2025 | -168.39 Mn |
| Mar 31, 2025 | -205.69 Mn |
| Dec 31, 2024 | -235.09 Mn |
| Sep 30, 2024 | -264.06 Mn |
| Jun 30, 2024 | -283.07 Mn |
| Mar 31, 2024 | -177.66 Mn |
| Dec 31, 2023 | -180.58 Mn |
| Sep 30, 2023 | -133.94 Mn |
| Jun 30, 2023 | -32.26 Mn |
| Mar 31, 2023 | -33.66 Mn |
| Dec 31, 2022 | -168.59 Mn |
| Sep 30, 2022 | -57.51 Mn |
| Jun 30, 2022 | -66.93 Mn |
| Mar 31, 2022 | -78.32 Mn |
| Dec 31, 2021 | -84.31 Mn |
| Sep 30, 2021 | -90.39 Mn |
| Jun 30, 2021 | -41.66 Mn |
| Mar 31, 2021 | -34.96 Mn |